Trials / Completed
CompletedNCT03259620
A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 491 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of six (6) weeks of once daily application of Furosemide Topical Gel 0.125% (CLS006) compared to vehicle in subjects ≥ 2 years of age with nongenital cutaneous common warts (verruca vulgaris).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CLS006 | Furosemide Topical Gel |
| DRUG | CLS006 Vehicle | Vehicle Topical Gel |
Timeline
- Start date
- 2017-10-30
- Primary completion
- 2018-08-22
- Completion
- 2018-11-07
- First posted
- 2017-08-23
- Last updated
- 2023-09-14
- Results posted
- 2023-09-14
Locations
35 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03259620. Inclusion in this directory is not an endorsement.